- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Entheon Biomedical Corp (ENBI)
Entheon Biomedical Corp stock price live, this page displays CSE ENBI stock exchange data. View the ENBI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Entheon Biomedical Corp real time stock price chart below.
What Is the Entheon Biomedical Corp Stock Price Today?
The Entheon Biomedical Corp stock price today is 0.10.
What Is the Stock Symbol for Entheon Biomedical Corp?
The stock symbol for Entheon Biomedical Corp is "ENBI."
What Stock Exchange Does Entheon Biomedical Corp Trade On?
Entheon Biomedical Corp is listed and trades on the CSE stock exchange.
Is Entheon Biomedical Corp a Good Stock to Buy?
Determining whether Entheon Biomedical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENBI quote. (ISIN: CA29383X2023)
What Is the Entheon Biomedical Corp Stock Price Today?
The Entheon Biomedical Corp stock price today is 0.10.
What Is the Stock Symbol for Entheon Biomedical Corp?
The stock symbol for Entheon Biomedical Corp is "ENBI."
What Stock Exchange Does Entheon Biomedical Corp Trade On?
Entheon Biomedical Corp is listed and trades on the CSE stock exchange.
Is Entheon Biomedical Corp a Good Stock to Buy?
Determining whether Entheon Biomedical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ENBI quote. (ISIN: CA29383X2023)
CSE
Currency in CAD
0.10
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.10
0.10
52 wk Range
0.07
0.37
ENBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.100.10
52 wk Range
0.070.37
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ENBI Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Entheon Biomedical Corp Company Profile
Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada.
Compare ENBI to Peers and Sector
Metrics to compare | ENBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipENBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.0x | −4.4x | −0.6x | |
PEG Ratio | −0.11 | −0.05 | 0.00 | |
Price/Book | 3.6x | 1.5x | 2.6x | |
Price / LTM Sales | - | 1.2x | 3.3x | |
Upside (Analyst Target) | - | 236.3% | 45.0% | |
Fair Value Upside | Unlock | 12.5% | 6.5% | Unlock |
Earnings
Latest Release
Sep 22, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Is the Entheon Biomedical (ENBI) Stock Price Today?
The Entheon Biomedical stock price today is 0.10
What Stock Exchange Does Entheon Biomedical Trade On?
Entheon Biomedical is listed and trades on the Canadian Securities Exchange.
What Is the Stock Symbol for Entheon Biomedical?
The stock symbol for Entheon Biomedical is "ENBI."
What Is the Entheon Biomedical Market Cap?
As of today, Entheon Biomedical market cap is 1.39M.
What Is Entheon Biomedical's Earnings Per Share (TTM)?
The Entheon Biomedical EPS (TTM) is -0.03.
From a Technical Analysis Perspective, Is ENBI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Entheon Biomedical Stock Split?
Entheon Biomedical has split 2 times.
How Many Employees Does Entheon Biomedical Have?
Entheon Biomedical has 1 employees.
What is the current trading status of Entheon Biomedical (ENBI)?
As of Feb 03, 2026, Entheon Biomedical (ENBI) is trading at a price of 0.10, with a previous close of 0.10. The stock has fluctuated within a day range of 0.10 to 0.10, while its 52-week range spans from 0.07 to 0.37.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.